Case report uncovers a novel heterozygous SLC2A9 variant causing severe renal hypouricemia in a child, indicating disrupted GLUT9 transport activity.
Congenital renal hypouricemia (RHUC) is a heterogeneous inherited disorder characterized by impaired tubular uric acid transport with severe complications, such as acute kidney injury. Type 1 is caused by a loss-of-function mutation in the SLC22A12 gene (URAT1), type 2 in the SLC2A9 gene (GLUT9). We describe the clinical history, biochemical and molecular genetic findings of a 3-year-old girl with severe hypouricemia (72–84 µmol/L), and an increased fractional excretion of uric acid (21.4–23.6%). Urinary xanthine and hypoxanthine concentrations were within the reference range. Sequencing analyses focusing on genes causing renal hypouricemia identified a new heterozygous variant c.340G > T (p.V114L) in exon 3 of the SLC2A9 gene. No sequence variants in other candidate uric acid transporter were found. Functional in vitro study with 14 C radiolabeled uric acid with HEK293-A cells showed significantly decreased urate uptake in this novel variant. Our findings provide a better pathogenic understanding of renal hypouricemia and the pathophysiological role of the GLUT9 transporter.
No takes yet. Share an insight, caveat, or question.
Vavra et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: